Page last updated: 2024-09-04

hyoscyamine and cycloheximide

hyoscyamine has been researched along with cycloheximide in 1 studies

Compound Research Comparison

Studies
(hyoscyamine)
Trials
(hyoscyamine)
Recent Studies (post-2010)
(hyoscyamine)
Studies
(cycloheximide)
Trials
(cycloheximide)
Recent Studies (post-2010) (cycloheximide)
9915519,1096861

Protein Interaction Comparison

ProteinTaxonomyhyoscyamine (IC50)cycloheximide (IC50)
COUP transcription factor 2 isoform aHomo sapiens (human)1.315
Glucose transporterLeishmania mexicana0.242
Hexose transporter 1 Plasmodium falciparum (malaria parasite P. falciparum)0.31
Solute carrier family 2, facilitated glucose transporter member 1Homo sapiens (human)0.228
Eukaryotic initiation factor 4A-IHomo sapiens (human)0.139
Peptidyl-prolyl cis-trans isomerase FKBP1AHomo sapiens (human)3.6
Hypoxia-inducible factor 1-alphaHomo sapiens (human)0.036
Endothelial PAS domain-containing protein 1Homo sapiens (human)0.036

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

1 other study(ies) available for hyoscyamine and cycloheximide

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012